By Nadia Dreid ( May 9, 2019, 10:31 PM EDT) -- Two techniques that lawmakers say brand-name pharmaceutical companies use to keep out generics companies could become enshrined in federal law as anti-competitive business practices if Sens. Richard Blumenthal and John Cornyn succeed at passing their new bill, announced Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.